Monday, November 9, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Cautious Normal choppiness · VIX 19.9
The NASDAQ 100 is in the grip of a severe semiconductor/AI-capex selloff, with NVDA, INTC, MU, AMAT, LRCX, KLAC, CRWV, NBIS and several memory/networking names down 20-45% from recent levels and well off 52-week highs. Capital appears to be rotating out of high-beta AI/semis and into defensives and consumer names — staples, healthcare, travel/leisure and business services are holding near 52-week highs with steady 5-day and 30-day gains. Given the breadth of tech damage, candidates below are concentrated in the pockets of genuine relative strength rather than the beaten-down growth names, which still carry high reversal risk and falling-knife dynamics.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | CCEP | SKIP | — | $117.49 → $123.80 stop $109.27 |
Position cap reached — 74 of 20 slots in use. |
| #2 | ADP | SKIP | — | $302.06 → $318.29 stop $280.92 |
Position cap reached — 74 of 20 slots in use. |
| #3 | IDXX | SKIP | — | $706.65 → $742.57 stop $648.00 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
Already open: HUM (to Nov 11), TJX (to Nov 11), UNH (to Nov 14), KO (to Nov 18), ULVR.L (to Nov 18), PFE (to Nov 19), ROST (to Nov 19), FAST (to Nov 20), CSX (to Nov 21), TRV (to Nov 22), SGE.L (to Nov 25), SVT.L (to Nov 25) … and 62 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Coca-Cola Europacific Partners bottles and distributes Coca-Cola products across Europe and parts of Asia-Pacific. The stock has been climbing steadily while tech shares have struggled, and it's trading above both its short- and long-term moving averages, a healthy technical sign. The main risk is that this steady, defensive stock could stall if money rotates back toward growth and tech names.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
ADP provides payroll and human-resources outsourcing services to businesses worldwide. The stock has been climbing steadily, comfortably outperforming the broader market, and sits above its key moving averages, a sign of a healthy uptrend. The main risk is that the rally could pause if economic data disappoints or momentum simply runs out of steam.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 62%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
IDEXX Laboratories makes diagnostic tests and lab equipment that vets use to detect pet illnesses. The company just reported much stronger revenue and profit growth than expected and raised its full-year outlook, and the stock has far outperformed the shaky broader tech market. The key risk is that the stock already jumped over 30% in the past month and short-term indicators look stretched, so a pause or pullback is possible even though the underlying business news is strong.
Why the AI likes it
What could go wrong
Calibrated probability: 59% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by December 9, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 101 NASDAQ 100 constituents and short-listed 28 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.